Intimation of earning conference call
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Aarti Drugs Ltd has announced a quarterly earnings conference call scheduled for May 18, 2026 at 11:00 AM IST to discuss the company's financial performance for the quarter ended March 31, 2026 (Q4 FY26). The call will feature key management including the Joint Managing Director, Whole-time Director, CFO & COO, and a representative from Pinnacle Life Science Private Limited. This filing is under Regulation 30 of SEBI LODR Regulations, 2015. Dial-in details for India, US, UK, Singapore, and Hong Kong have been provided along with pre-registration links.
This is a standard investor relations activity indicating the company is proactively engaging with analysts and investors post Q4 FY26 results. While the filing itself doesn't contain financial data, it signals upcoming communication that could include business outlook and performance commentary. Shareholders and analysts can prepare questions on the company's quarterly performance and future trajectory.